European Heart Journal Advance Access originally published online on April 27, 2006
European Heart Journal 2006 27(11):1305-1310; doi:10.1093/eurheartj/ehi882
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Intravascular ultrasound predictors of angiographic restenosis after sirolimus-eluting stent implantation
1 Department of Medicine, University of Ulsan College of Medicine, Asan Medical Center, 388-1 Poongnap-dong, Songpa-gu, Seoul, 138-736, Korea
2 Cardiovascular Research Foundation, New York, NY, USA
3 Department of Medicine, University of Ulsan College of Medicine, Asan Medical Center, GangNeung, Korea
Received 13 November 2005; revised 2 March 2006; accepted 23 March 2006; online publish-ahead-of-print 27 April 2006.
* Corresponding author. fax: +82 2 475 6898. E-mail address: sjpark{at}amc.seoul.kr
Aims In many countries, drug-eluting stent implantation is the dominant interventional strategy. We evaluated the clinical, angiographic, procedural, and intravascular ultrasound (IVUS) predictors of angiographic restenosis after sirolimus-eluting stent (SES) implantation.
Methods and results SES implantation was successfully performed in 550 patients with 670 native coronary lesions. Six-month follow-up angiography was performed in 449 patients (81.6%) with 543 lesions (81.1%). Clinical, angiographic, procedural, and IVUS predictors of restenosis were determined. Using multivariable logistic regression analysis, the only independent predictors of angiographic restenosis were post-procedural final minimum stent area by IVUS [odds ratio (OR)=0.586, 95% confidence interval (CI) 0.3870.888, P=0.012] and IVUS-measured stent length (OR=1.029, 95% CI 1.0021.056, P=0.035). Final minimum stent area by IVUS and IVUS-measured stent length that best separated restenosis from non-restenosis were 5.5 mm2 and 40 mm, respectively. Lesions with final minimum stent area <5.5 mm2 and stent length >40 mm had the highest rate of angiographic restenosis [17.7% (11/62)], P<0.001 compared with other groups.
Conclusion Independent predictors of angiographic restenosis after SES implantation were post-procedural final minimum stent area by IVUS and IVUS-measured stent length. The angiographic restenosis rate was highest in lesions with stent area <5.5 mm2 and stent length >40 mm.
Key Words: Ultrasonics Stent Coronary disease
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J.-Y. Hahn, Y. B. Song, S.-Y. Lee, J.-H. Choi, S.-H. Choi, D. K. Kim, S. H. Lee, and H.-C. Gwon Serial Intravascular Ultrasound Analysis of the Main and Side Branches in Bifurcation Lesions Treated With the T-Stenting Technique. J. Am. Coll. Cardiol., July 7, 2009; 54(2): 110 - 117. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. Stone and G. S. Mintz Unprotected Left Main Intervention: The Light at the End of the Tunnel? Circ Cardiovasc Intervent, June 1, 2009; 2(3): 156 - 158. [Full Text] [PDF] |
||||
![]() |
X. Liu, H. Doi, A. Maehara, G. S. Mintz, J. de Ribamar Costa Jr, K. Sano, G. Weisz, G. D. Dangas, A. J. Lansky, E. M. Kreps, et al. A Volumetric Intravascular Ultrasound Comparison of Early Drug-Eluting Stent Thrombosis Versus Restenosis J. Am. Coll. Cardiol. Intv., May 1, 2009; 2(5): 428 - 434. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Roy, D. H. Steinberg, S. J. Sushinsky, T. Okabe, T. L. Pinto Slottow, K. Kaneshige, Z. Xue, L. F. Satler, K. M. Kent, W. O. Suddath, et al. The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents Eur. Heart J., August 1, 2008; 29(15): 1851 - 1857. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Honda and P. J. Fitzgerald Frontiers in Intravascular Imaging Technologies Circulation, April 15, 2008; 117(15): 2024 - 2037. [Full Text] [PDF] |
||||
![]() |
E. Romagnoli, G. M. Sangiorgi, J. Cosgrave, E. Guillet, and A. Colombo Drug-eluting stenting the case for post-dilation. J. Am. Coll. Cardiol. Intv., February 1, 2008; 1(1): 22 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Daemen and P. W. Serruys Drug-Eluting Stent Update 2007: Part II: Unsettled Issues Circulation, August 21, 2007; 116(8): 961 - 968. [Full Text] [PDF] |
||||
![]() |
G. S. Mintz What to Do About Late Incomplete Stent Apposition? Circulation, May 8, 2007; 115(18): 2379 - 2381. [Full Text] [PDF] |
||||
![]() |
G. S. Mintz and N. J. Weissman Intravascular Ultrasound in the Drug-Eluting Stent Era J. Am. Coll. Cardiol., August 1, 2006; 48(3): 421 - 429. [Abstract] [Full Text] [PDF] |
||||




